MYRIAD GENETICS, INC. (MYGN) Shareholders’ equity 2016–2025
MYRIAD GENETICS, INC. (MYGN) shareholders’ equity at each fiscal year-end, per SEC filings.
$368.0MFY2025 · since FY2016: $739.6M → $368.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $368.0M | -47.5% |
| FY2024 | $701.1M | -10.5% |
| FY2023 | $783.2M | -11.6% |
| FY2022 | $885.8M | -8.5% |
| FY2021 | $967.8M | +9.9% |
| FY2020 | $881.0M | -19.1% |
| FY2019 | $1.1B | +12.7% |
| FY2018 | $966.1M | +25.7% |
| FY2017 | $768.4M | +3.9% |
| FY2016 | $739.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice